Clinical Trial Update: To Test Bioequivalence Between Two Formulations of Paracetamol/Phenylephrine [Phase 1]

View source ↗

Summary

A Phase 1 bioequivalence study comparing two Paracetamol/Phenylephrine formulations for respiratory tract infections has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Respiratory Tract Infection

Drugs mentioned

• Paracetamol/Phenylephrine (paracetamol/phenylephrine)

Snippet

Sponsor: McNeil AB | Conditions: Respiratory Tract Infections | Phase 1 | Status: COMPLETED